IRIS
ZENTILIN, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.692
Totale 15.692
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.692
Totale 15.692
Salva come PNG Salva come JPEG
Città #
Genova 12.851
Rapallo 1.742
Genoa 1.065
Bordighera 34
Totale 15.692
Salva come PNG Salva come JPEG
Nome #
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 168
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers 161
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 156
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery 155
Time pattern of gastric acidity in Barrett's esophagus 149
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 143
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 138
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. 136
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 136
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 134
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 133
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 133
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 132
Advancements in the use of manometry and impedance testing for esophageal functional disorders 128
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 127
NERD: an umbrella term including heterogeneous subpopulations. 125
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 123
Endotherapy for and tailored approaches to treating GERD, and refractory GERD 123
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 122
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 122
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations 121
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 121
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 120
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 120
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 119
Esophageal acid exposure still plays a major role in patients with NERD. 119
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 118
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 118
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 117
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 117
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data 117
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 116
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 116
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori 115
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 115
The relevance of weakly acidic reflux in patients with Barrett's esophagus. 115
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 113
A safety review of proton pump inhibitors to treat acid-related digestive diseases 113
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. 112
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 112
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 111
Helicobacter pylori and tolerance to H2-blockers. 110
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity 110
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 109
Proton pump inhibitors: use and misuse in the clinical setting 109
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 107
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 107
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study 106
The role of Acid in functional dyspepsia. 106
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 106
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 105
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 104
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 103
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. 102
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 102
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 102
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? 101
Nonerosive reflux disease and functional heartburn are clearly separate entities. 101
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 101
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 100
Esophageal acid exposure still plays a major role in patients with NERD. 100
Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition? 100
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. 99
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 99
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. 98
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease 98
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 98
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 97
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. 97
Achalasia with Dense Eosinophilic Infiltrate Responding To Steroidal Treatment. 96
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 96
Non-erosive reflux disease is more complex than negative endoscopy only. 96
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. 96
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 95
The appropriate use of proton-pump inhibitors 94
Once-Daily Bedtime Dose of Roxatidine and Ranitidine in Acute Duodenal Ulcer: A Combined Assessment of Acid Inhibitory Activity and Healing Rate. 93
Functional testing: pharyngeal pH monitoring and high-resolution manometry. 93
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. 92
Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. 92
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately. 92
MIB-1 Proliferation Index of squamous epithelium in gastroesophageal reflux disease. Correlations with clinical, Endoscopic and Morphological data. 91
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 91
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 90
The reason for failure of on-demand PPI therapy in NERD patients. 90
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. 90
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis 90
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 89
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 88
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. 88
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 88
It is time to plan clinical trials on true NERD patients. 88
Epidemiology and natural history of gastroesophageal reflux disease 87
Light microscopy is useful to better define NERD and functional heartburn. 86
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. 85
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. 84
Duration of acid suppression in H2-antagonist nonresponders. 84
Duodenal ulcer resistant to usual omeprazole dose. 84
Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring. 83
null 83
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. 83
Totale 10.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.066
article - articoli 36.958
book - libri 322
conference - conferenze 459
curatela - curatele 0
other - altro 3.800
patent - brevetti 0
selected - selezionate 0
volume - volumi 527
Totale 84.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019788 0 0 0 0 0 0 0 0 0 0 440 348
2019/20204.583 195 105 197 272 434 470 693 324 426 789 467 211
2020/20211.391 72 155 132 115 71 127 88 149 147 138 97 100
2021/20222.102 107 156 179 282 75 144 163 405 82 210 65 234
2022/20232.094 223 130 21 190 442 312 1 167 367 13 203 25
2023/2024758 49 123 24 115 94 157 64 49 59 21 3 0
Totale 15.879